Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Snail1 Induced Suppression of Proliferation via EGR1, FOXO1, and CEPBγ Creates a Vulnerability for Targeting Apoptotic and Cellular Senescence Pathways.

Cancers·2026
Same author

Publisher Correction: Tetraspanin-enriched membrane domains regulate vascular leakage by altering membrane cholesterol accessibility to balance antagonistic GTPases.

Nature cardiovascular research·2025
Same author

Tetraspanin-enriched membrane domains regulate vascular leakage by altering membrane cholesterol accessibility to balance antagonistic GTPases.

Nature cardiovascular research·2025
Same author

Microfluidic Flow Promotes a Steatotic Phenotype in Induced Pluripotent Stem Cell-Derived Hepatocytes that is Influenced by Disease State of the Donor.

Gastro hep advances·2025
Same author

Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma.

The Journal of clinical investigation·2025
Same author

Corrigendum: Microfluidic-based human prostate-cancer-on-chip.

Frontiers in bioengineering and biotechnology·2024

Related Experiment Video

Updated: Jun 9, 2025

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.0K

Microfluidic Applications in Prostate Cancer Research.

Kailie Szewczyk1, Linan Jiang1, Hunain Khawaja2

  • 1Department of Aerospace and Mechanical Engineering, University of Arizona, Tucson, AZ 85721, USA.

Micromachines
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

Microfluidic organ-on-chip technology offers a new way to study prostate cancer, improving on traditional models. This approach aids in understanding and potentially treating advanced prostate cancer.

Keywords:
detection and therapydormancymetastasismicrofluidicsprostate cancer

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K

Related Experiment Videos

Last Updated: Jun 9, 2025

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.0K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K

Area of Science:

  • Oncology
  • Biotechnology
  • Bioengineering

Background:

  • Prostate cancer is a leading cause of cancer death in men, often due to metastasis.
  • Traditional cell cultures and animal models have limitations in predicting human physiological responses.
  • Microfluidics offers advanced in vitro models that better mimic in vivo microenvironments.

Purpose of the Study:

  • To review recent microfluidic applications in prostate cancer research.
  • To highlight microfluidics' role in modeling prostate cancer initiation, development, detection, and therapy.
  • To discuss the potential of microfluidics in overcoming challenges in treating metastatic castration-resistant prostate cancer.

Main Methods:

  • Review of existing literature on microfluidic systems for prostate cancer research.
  • Analysis of organ-on-chip and other microphysiological systems.
  • Discussion of technological advancements and their application to prostate cancer.

Main Results:

  • Microfluidic systems, including organ-on-chips, can effectively model human prostate tissue and disease progression.
  • These systems provide superior microenvironments compared to traditional models.
  • Microfluidics shows promise in advancing prostate cancer detection and therapeutic strategies.

Conclusions:

  • Microfluidics represents a paradigm shift in life sciences, particularly for cancer research.
  • Organ-on-chip technology bridges the gap between traditional models and in vivo studies.
  • Microfluidic applications hold significant potential for the future eradication of prostate cancer.